Candriam Eq. L Biotechnology C Dis $

Principal assets traded:Equities of companies active in biotechnology whose registered offices and/or principal activities are throughout the world.Investment strategy:The fund seeks to achieve capital growth by investing in the principal assets traded and to outperform the benchmark.The management team makes discretionary investment choices based on economic/financial analyses.There are two strands in the selection of companies: a clinical analysis and a fundamental analysis.The clinical analysis aims to assess the quality of the available clinical data and to use only companies found to be convincing in this respect.The fundamental analysis selects the best companies according to five criteria: quality of management, growth potential, competitive advantage, value creation and indebtedness.The fund promotes, among other characteristics, environmental and/or social characteristics but does not have sustainable investment as its objective. The analysis of ESG aspects (environment, social, governance) is included in the selection, analysis and global evaluation of companies. The Fund also aims to exclude investments in companies which do not respect certain recognised international standards and principles, or which are significantly exposed to certain controversial activities. Under certain conditions, the analysis and selection process may also be accompanied by active involvement, in particular dialogue with companies and voting as the shareholder at AGMs. For more information, please see the management company's website and/or the prospectus.The fund may make use of derivative products for both investment and hedging purposes (to protect against future unfavourable financial events).Benchmark: NASDAQ Biotechnology Index (Net Return). The fund is managed actively and the investment approach implies a reference to a benchmark (the index).Benchmark definition:The index measures the performance of NASDAQ-listed companies from the biotechnology and pharmaceuticals sect

PIR compliant

No

PEA compliant

No

PEA-PME compliant

No